北美成瘾治疗市场预测至 2027 年 - COVID-19 影响和按治疗类型划分的区域分析（尼古丁成瘾治疗、酒精成瘾治疗、阿片类药物成瘾治疗、其他药物成瘾治疗）；药物类型（伐尼克兰、安非他酮、尼古丁替代产品、丁丙诺啡、纳曲酮、双硫仑等）；治疗中心（门诊治疗中心、住院治疗中心、住院治疗中心）；分销渠道（医院、药店、其他）和国家
No. of Pages: 94 | Report Code: TIPRE00017280 | Category: Life Sciences
No. of Pages: 94 | Report Code: TIPRE00017280 | Category: Life Sciences
成瘾是一种心理和身体上无法停止消费毒品、酒精、阿片类药物和相关类别物质的行为，尽管这些物质有各种精神和身体危害。成瘾会使人对服用该物质产生依赖性。所以，要戒毒，有多种选择，比如药物治疗、康复治疗，可以更好的戒毒。
北美成瘾治疗市场预计将到达美国到 2027 年，这一数字将从 2019 年的 37.1523 亿美元增至 61.0231 亿美元。预计 2020 年至 2027 年，该市场将以 6.5% 的复合年增长率增长。市场的增长归因于新药批准的增加和数字疗法的推出毒瘾、开展各种提高认识运动以及政府努力打击药物滥用和推广药物治疗。然而，与药物开发相关的高成本阻碍了成瘾治疗市场的增长。
根据治疗类型，北美成瘾治疗市场分为尼古丁成瘾治疗、酒精成瘾治疗、阿片类药物成瘾治疗等物质成瘾治疗。尼古丁成瘾治疗细分市场在 2019 年占据最大市场份额，预计在预测期内复合年增长率最高。
北美成瘾治疗市场根据药物类型，分为伐尼克兰、安非他酮、尼古丁替代产品、丁丙诺啡、纳曲酮、双硫仑等。伐尼克兰细分市场在 2019 年占据最大的市场份额。然而，预计尼古丁替代产品细分市场在预测期内的复合年增长率最高。
按治疗中心划分北美成瘾治疗市场分为门诊治疗中心、住院治疗中心和住院治疗中心。 2019年，门诊治疗中心细分市场占据最大市场份额，预计在预测期内复合年增长率最高。
北美成瘾治疗市场根据分销渠道分为医院药房、医疗商店等。医院药房细分市场在 2019 年占据最大市场份额。然而，预计医疗商店细分市场在预测期内的复合年增长率最高。
;
一些与本北美成瘾治疗市场报告相关的主要和次要来源是美国食品和药物管理局 (FDA)；疾病控制与预防中心 (CDC)；和美国成瘾中心 (AAC)。
< /p>
按药物类型
按治疗中心
按分销渠道
Strategic insights for North America Addictions Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 3,715.23 Million |
| Market Size by 2027 | US$ 6,102.31 Million |
| Global CAGR (2020 - 2027) | 6.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 治疗类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Addictions Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Addictions Therapeutics Market is valued at US$ 3,715.23 Million in 2019, it is projected to reach US$ 6,102.31 Million by 2027.
As per our report North America Addictions Therapeutics Market, the market size is valued at US$ 3,715.23 Million in 2019, projecting it to reach US$ 6,102.31 Million by 2027. This translates to a CAGR of approximately 6.5% during the forecast period.
The North America Addictions Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Addictions Therapeutics Market report:
The North America Addictions Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Addictions Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Addictions Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Addictions Therapeutics Market
